In the afternoon, it was not long before the moment when the discussion began. It was also at this time that Xia Junxin met with the classmates in the class.

The students in the class sat under the audience as spectators, surrounded by other teams. And then in the front row are some teams of experts.

Xia Junxin, under the leadership of Zhong Rushuang, entered one of the seats and sat down.

What Xia Junxin didn't expect was that this academic exchange caused a sensation among many foreign research teams, and they also came by plane overnight.

The host said to the audience on the stage: "Today, the topic of our research and discussion is medical nanorobots, and we have used nanorobots to conduct a series of clinical experiments, and today, we will get new examination results." ”

Behind the moderator, a huge screen lit up with volunteers who participated in the experiment, most of whom were terminally ill.

Each experiment is preceded by a short introduction, either as a memorial or as an explanation of dedication to the advancement of medical science......

There were all kinds of people, about ten people, and the short films given were very ordinary, but they were also shocking.

Xia Junxin is no stranger to the conditions of these ten people, and she has also read their materials before: five patients with advanced tumors, three patients with leukemia, one patient with hypertension, and one patient with HIV.

The host said: "According to the imagination of scientists, our medical nanorobots should be able to be injected into human blood vessels for various maintenance, treatment, organ repair, etc.

However, there is still a long way to go between the idea and the actual realization of clinical medicine. And today is the first step in our long journey.

Let's take a look at the research results of each team, and first invite the first leader of the research team to the stage and give us a brief introduction to their situation. ”

On stage was a middle-aged man with glasses: "Hello everyone, our research team has developed a microrobot that moves by DNA and can undergo physical changes at specific signals, just like amoebae...... At present, we have implanted the microrobot into the patient. ”

The moderator asked, "Excuse me, what is the main treatment method of this robot you are studying?" ”

The man replied, "Precision dosing." ”

The host said, "Okay, then let's contact the medical staff at the hospital." Take a look at the patient's condition management as your team. ”

At this time, the hearts of the whole audience were nervous, if this kind of nanorobot, precision drug delivery technology was successful. This is a great step forward in the history of mankind.

If it fails, then let's talk about why they failed.

The screen shows the condition of one of the patients. He was a patient with a tumor, and he was still lying on a white hospital bed, and he didn't look much different from before.

The camera then pans to the scanning room. It just so happened that the patient was administering drugs with a microrobot......

On the screen, the walls of the blood vessels around the liver in the patient's abdominal cavity are displayed. At first, the tiny, barely visible microrobots were functioning.

Those robots seem to be in order.

But suddenly, the picture changed, and a strange sound came from inside......

Then, the instrument siren sounded.

The doctor quickly zoomed in on the camera and said seriously: "The patient is hypereclamped, and it is suspected that some microrobots have accidentally injured the blood vessels after they malfunctioned out of control......"

"The attending physician is in place, emergency rescue!"

……